Grenoble, March 6th, 2025 — Quobly, a leading European quantum computing company, and BGene, a specialist in biotechnology and bioinformatics, today announced a strategic partnership to explore the transformative potential of quantum computing in biotechnology. This collaboration aims to accelerate the discovery of bio-based molecules, optimize bioprocesses, and drive sustainable innovation.
« We are thrilled to partner with BGene. This collaboration represents a major milestone for Quobly, allowing us to demonstrate the real-world value of quantum computing in industrial applications such as biotechnology. Together, we aim to pave the way for groundbreaking, eco-friendly solutions, » said Maud Vinet, President of Quobly.
Marie-Gabrielle Jouan, President of BGene, added: « Integrating quantum computing for computational chemistry applications opens up fascinating possibilities in our enzymatic modeling processes. This partnership with Quobly will not only accelerate our research but also strengthen our position as an innovative and sustainable player in the global market.«
The strategic partnership will focus on developing a joint use case that combines quantum computing power with biotechnological expertise to tackle major scientific and industrial challenges.
About Quobly
Founded in 2022 and based in Grenoble, Quobly develops universal quantum processors based on silicon spin technology. By leveraging proven semiconductor manufacturing processes, Quobly aims to democratize access to quantum computing for solving complex industrial problems.
About BGene
Founded in 2014, BGene specializes in developing sustainable biotechnological solutions. With its integrated bioinformatics and biotechnology platform, BGene delivers high-value natural ingredients for the cosmetics, food, and pharmaceutical industries.
Press Contacts
BGene: Marie-Gabrielle Jouan, Présidente, mgj@bgene-genetics.com
Quobly: Annick Gingras-Genois, SVP HR and organization Quobly, Annick.gingras-genois@quobly.io
